Abcellute's core technology is based on a novel matrix which permits the preservation and storage of fresh primary liver cells or hepatocytes for up to 5 days at non-freezing temperatures without loss of biological function or principle biomarkers.The company's primary strategy is to attain global adoption of its cell preservation platform technology, thereby providing the research community with enhanced cell systems to improve management and development of key areas such as pre-clinical drug evaluation and regenerative medicine.